BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 21, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Regulatory actions for Jan. 28, 2020

Jan. 28, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations, including: Alkermes, Arrevus, Blueberry, Boehringer Ingelheim, Eli Lilly, Janssen, Jubilant, Regeneron, Sanofi and Surface
Read More

Other news to note for Jan. 28, 2020

Jan. 28, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief, including: Adverum, Achillion, Alexion, Armata, Atrin, Avacta, Biolexis, Clover, Concert, Correvio, Horizon, Incyte, Innovia, Outlook, Oxford Gene, Predictive Technology, Satt Conectus, Seelos, Syndivia, Takeda
Read More

In the clinic for Jan. 28, 2020

Jan. 28, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications, including: Acceleron, Aeterna Zentaris, Bausch Health, Cassava, Clearside, Ikena, Incyte, Syros
Read More

Financings for Jan. 28, 2020

Jan. 28, 2020
Biopharmas raising money in public or private financings, including: Applied Therapeutics, Autolus, Concert, Denali, Immunogen, Intelgenx, Vascular Therapies, Vaxil, Xenon
Read More

Regulatory actions for Jan. 27, 2020

Jan. 28, 2020

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations, including: Affiris, Corium, Genentech, Merck, Neoimmunetech, Pharmacyte


Read More

Clinical data for Jan. 21-27, 2020

Jan. 28, 2020
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astellas, Astrazeneca, Beigene, Cstone, Daiichi Sankyo, Epygenix, Hutchison China Meditech, Isofol Medical, Oric
Read More

Regulatory actions for Jan. 27, 2020

Jan. 27, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cognita Labs, Jubilant Pharma, Imricor Medical Systems, Mauna Kea Technologies
Read More

In the clinic for Jan. 27, 2020

Jan. 27, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications, including: Saluda Medical, Soliton
Read More

Other news to note for Jan. 27, 2020

Jan. 27, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Allergan, Anika Therapeutics, Bioivt, Electrocore, Halma, Parcus Medical, Suntech Medical, Ucyte Technologies, Valencell
Read More

Financings for Jan. 27, 2020

Jan. 27, 2020
Med-tech firms raising money in public or private financings, including: Loop+, Pharmaceutical Product Development, Ulab Systems, Valencell
Read More
Previous 1 2 … 1662 1663 1664 1665 1666 1667 1668 1669 1670 … 1757 1758 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing